Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 5Sleep Apnea, Obstructive 2Breast Neoplasms 2Sleep Apnea Syndromes 1Osteoporosis 1Obesity 1Myocardial Ischemia 1Metabolic Syndrome 1Insulin Resistance 1Hyperandrogenism 1Heart Diseases 1Glucose Intolerance 1Estrogen Receptor Positive Breast Cancer 1Coronary Disease 1Colonic Neoplasms 1Cardiovascular Diseases 1Bone Diseases 1

Interventions

Metformin 7Magnetic Resonance Spectroscopy 2Inositol 2Exercise 2Ethinyl Estradiol 2maltodextrin 1drospirenone and ethinyl estradiol combination 1drospirenone 1Walking 1Triptorelin Pamoate 1Testosterone 1Sugars 1Spironolactone 1Pyruvic Acid 1Preoperative Exercise 1Pioglitazone 1Phlebotomy 1Pancreaticoduodenectomy 1Orchiectomy 1Leuprolide 1Hepatectomy 1Flutamide 1Etanercept 1Estrogens 1Diet, Reducing 1Diet, Mediterranean 1Diet, Fat-Restricted 1Diet Therapy 1Diet 1Diathermy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Metabolic Syndrome × Estrogens × Clear all
NCT00203996 2023-03-21

Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

University of Chicago

Phase 4 Terminated
37 enrolled 15 charts

Insulin Resistance, Polycystic Ovary Syndrome, Glucose Intolerance, Sleep Apnea, Obstructive, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡